Namwiwat Medical Corporation PCL (BKK:NAM)
Thailand flag Thailand · Delayed Price · Currency is THB
3.360
-0.020 (-0.59%)
At close: Aug 10, 2026

BKK:NAM Financials Overview

Millions THB. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,7091,8701,1141,1011,100995.36
Revenue Growth
17.74%67.79%1.24%0.04%10.55%46.63%
Gross Profit
487.4540.57467.87480.05327.45340.63
Operating Income
91.73155.9212.33249.9224.06225.45
Net Income
68.17101.59180.87200.75175.71174.65
Earnings Per Share
0.100.150.260.336.688.73
EPS Growth
-67.16%-43.83%-20.90%-95.11%-23.46%56.17%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Manufacturing and Distribution of Medical Equipment
1,0461,211628.42668.66590.65629.83
CSSD Sterilization Services, Medical Equipment Maintenance Services and Infectious Waste Services (SV)
296.16286.07176.03152.7--
Others
6.887.746.064.62--
Manufacture and Distribute of Medical Supplies
374.31365.28303.88249.01296.42227.42
Total
1,7091,8701,1141,101887.07857.25

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
678.12698.78980.781,099359.640.86
Total Debt
472.67495.31349.8231.35263.27374.89
Net Cash (Debt)
205.44203.47630.98867.2296.34-334.03
Net Cash Growth
-56.02%-67.75%-27.24%800.18%--
Net Cash Per Share
0.290.290.901.413.66-16.70

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3.7137.8622.94258.68-81.1693.61
Capital Expenditures
-39.01-42.79-55.57-30.41--
Free Cash Flow
-35.29-4.94-32.64228.27-81.1693.61
Free Cash Flow Growth
------10.60%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
28.52%28.91%41.98%43.61%29.76%34.22%
Operating Margin
5.37%8.34%19.05%22.70%20.36%22.65%
Pretax Margin
5.07%7.98%20.81%22.74%20.17%21.48%
Profit Margin
3.99%5.43%16.23%18.24%15.97%17.55%
FCF Margin
-2.07%-0.26%-2.93%20.74%-7.38%9.40%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.1300.1300.1500.090
Dividend Per Share Growth
-13.33%-13.33%66.67%-
Dividend Yield
3.85%3.74%3.50%1.42%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
34.5024.1217.8024.23--
Forward PE
-13.7613.7617.38--
P/FCF Ratio
---21.31--
PS Ratio
1.381.312.894.42--